SSX5 and cancer: SSX5 belongs to the synovial sarcoma X breakpoint proteins family and functions as transcriptional repressors eliciting spontaneous cellular and humoral immune responses in cancer patients, and thus it is potentially useful target in cancer vaccine-based immunotherapy [30].